FTC sues important pharmacy benefit managers more than insulin prices The agency introduced motion versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the listing price of lifestyle-saving insulin drugs. Before this summertime, the organization held lengthy negotiations with Steward in excess of https://kethek.com/